Analgesics Market Analysis, Development, and Forecast by 2031

Coverage: Analgesics Market covers analysis By Product Type (Non-opioids, Opioids); Route of Administration (Oral, Intravenous, Rectal, Transdermal, Topical); Pain Type (Surgical Pain, Cancer Pain, Neuropathic Pain, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Store, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00007240
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

The Analgesics Market is expected to register a CAGR of 6.4% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented by Product Type (Non-opioids, Opioids); Route of Administration (Oral, Intravenous, Rectal, Transdermal, Topical), and Pain Type (Surgical Pain, Cancer Pain, Neuropathic Pain, Others). The global analysis is broken down at the regional level and for major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Analgesics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Analgesics Market Segmentation

Product Type
  • Non-opioids
  • Opioids
Route of Administration
  • Oral
  • Intravenous
  • Rectal
  • Transdermal
  • Topical
Pain Type
  • Surgical Pain
  • Cancer Pain
  • Neuropathic Pain
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Store

Strategic Insights

Analgesics Market Growth Drivers
  • Increasing Prevalence of Chronic Pain Conditions: One of the major growth drivers in the analgesics market is the rising prevalence of chronic pain conditions. Chronic pain, particularly musculoskeletal disorders, neuropathic pain, and conditions like arthritis, is becoming more widespread globally. The increasing aging population, along with rising rates of lifestyle diseases such as obesity, is contributing to higher instances of chronic pain. As a result, there is a growing demand for analgesics to manage these conditions effectively. The global market for pain management is projected to expand significantly, driven by the increasing need for treatments that offer long-term relief. Chronic pain is not only a health burden but also has economic implications, with a substantial number of working adults experiencing diminished productivity and quality of life. This has led to the development of more specialized pain management medications. Forecasts suggest that the analgesics market will continue to grow as the demand for pain relief products increases in response to the global chronic pain epidemic. As healthcare providers focus on managing pain and improving the quality of life for patients, the analgesics market size is expected to expand rapidly, with strong growth in market share for both prescription and over-the-counter (OTC) products.
  • Rising Awareness of Pain Management Treatments: Increased awareness and education about pain management treatments have played a significant role in driving the analgesics market. With more patients and healthcare providers understanding the importance of addressing pain early, the demand for effective pain relief options is growing. Public health campaigns, combined with digital platforms that provide information about pain management strategies, have helped reduce the stigma associated with pain disorders. Market forecasts show that this growing awareness will fuel the adoption of analgesic drugs, particularly in populations previously under-treated for pain. As individuals become more educated about available options, they are more likely to seek treatment, thereby expanding the market for analgesics. This driver is especially relevant in emerging markets where access to pain management therapies has historically been limited. In addition, advancements in digital health tools, such as mobile apps and wearable devices, enable better monitoring and management of pain, further contributing to market growth. Pain education is also helping healthcare professionals better understand the importance of personalized pain relief, leading to the development of more targeted and effective analgesic drugs. With an increasing number of patients seeking tailored pain treatments, the market share for analgesics is poised for long-term expansion.
  • Advancements in Pain Management Medications: Advancements in pain management medications have also been a major driver for the analgesics market. New classes of pain relief drugs, as well as innovations in drug delivery systems, have enhanced the efficacy and safety profiles of analgesics. For example, the development of non-opioid analgesics has responded to the global opioid crisis by providing alternative solutions for pain management. Research and development efforts are focusing on creating pain medications that have fewer side effects, are more targeted, and offer long-lasting relief. Novel drug formulations such as extended-release versions and combination therapies have further expanded treatment options. Market forecasts indicate that the analgesics market will benefit from ongoing innovations in pain relief, particularly as the medical community continues to explore new ways to manage pain more effectively. The trend toward personalized medicine and the identification of pain biomarkers is also driving innovation in analgesics, as patients can receive therapies tailored to their specific needs. Additionally, the approval of new biologics and gene therapies for pain management is expected to further expand market opportunities. These innovations will not only improve patient outcomes but also lead to higher market shares for pharmaceutical companies that can develop and distribute these new pain management therapies.
Analgesics Market Future Trends
  • Shift Toward Non-Opioid Pain Management: A key trend in the analgesics market is the shift toward non-opioid pain management solutions. With the increasing awareness of the risks associated with opioid use, including addiction and overdose, healthcare providers are increasingly turning to non-opioid analgesics for pain relief. Nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and newer classes of pain medications, such as nerve blockers, are gaining popularity as safer alternatives. Market forecasts predict that the demand for non-opioid pain medications will continue to rise as patients and healthcare providers seek alternatives to opioids. This trend is particularly strong in the treatment of chronic pain conditions, such as osteoarthritis and neuropathic pain, where long-term opioid use is considered problematic. The development of new, non-opioid medications with fewer side effects is expected to fuel this trend and expand the overall analgesics market. Additionally, advances in drug delivery technologies, such as transdermal patches and sustained-release formulations, are further driving this shift toward safer and more effective pain management options. The focus on reducing opioid prescriptions in favor of non-opioid alternatives will significantly impact the market’s future landscape, leading to both growth and market diversification.
  • Rise in Personalized Pain Management Solutions: Personalized medicine is a growing trend in the analgesics market. Advances in genomics and biomarkers are allowing healthcare providers to better understand individual pain profiles, leading to more targeted therapies. Pain is a complex and subjective experience, and what works for one patient may not be effective for another. By tailoring analgesic treatments based on a patient’s genetic makeup and specific pain pathways, healthcare providers can achieve better outcomes. Market forecasts indicate that personalized pain management solutions will become increasingly common, particularly for chronic pain patients, who often require long-term and individualized treatment plans. Additionally, the development of companion diagnostics that can assess a patient’s response to pain medications will help guide treatment decisions. The rise of digital health tools and telemedicine also plays a role in personalized pain management, as patients can receive continuous monitoring and real-time adjustments to their pain management strategies. This trend is expected to drive the growth of the analgesics market as demand increases for more customized solutions that are both more effective and less prone to side effects. Personalized analgesics will also support the increasing adoption of non-opioid pain treatments, offering a more holistic approach to pain management.
  • Expansion of Over-the-Counter (OTC) Pain Relief Products: The expansion of over-the-counter (OTC) pain relief products is a prominent trend in the analgesics market. Consumers are increasingly seeking accessible, cost-effective solutions for mild to moderate pain, such as headaches, back pain, and muscle soreness. OTC analgesics, including NSAIDs, acetaminophen, and topical creams, are being widely used for self-management of pain. The growth of the OTC segment is fueled by the increasing preference for self-care, as well as the desire to avoid potential side effects of prescription drugs. Forecasts predict that the OTC pain relief market will continue to expand as consumers become more proactive about managing pain without requiring a doctor’s visit. In response, pharmaceutical companies are introducing new formulations and product variations, including products with extended-release features or those designed for specific types of pain. The convenience, affordability, and availability of OTC analgesics are contributing to their growing market share. As health-conscious consumers look for convenient pain relief options, the demand for OTC products is expected to increase, driving overall market growth. Additionally, the shift toward OTC pain relief options is supported by the growing emphasis on preventive healthcare and lifestyle management.
Analgesics Market Opportunities
  • Growth of Chronic Pain Management Solutions: The increasing demand for chronic pain management solutions presents a major opportunity in the analgesics market. Chronic pain conditions, including arthritis, fibromyalgia, and neuropathy, are among the most common reasons people seek medical treatment. As the global prevalence of chronic pain continues to rise, driven by aging populations and lifestyle factors, the need for effective and long-lasting pain management therapies will expand. New treatments, including biologics and advanced drug delivery systems, offer promising opportunities for market growth. Companies are investing in the development of therapies that not only provide pain relief but also address the underlying causes of chronic pain. Market forecasts suggest that the growing focus on long-term, personalized pain management will drive demand for both prescription and OTC analgesics, expanding the overall market size. With more patients seeking solutions for chronic pain, this presents a lucrative opportunity for manufacturers to innovate and capture a larger share of the pain relief market.
  • Increasing Use of Digital Health Tools for Pain Management: The integration of digital health tools for pain management presents a growing opportunity in the analgesics market. Innovations such as mobile applications, wearable devices, and telemedicine are allowing patients to monitor and manage their pain more effectively. These tools are particularly valuable for chronic pain patients, who require ongoing management and personalized treatment. Digital platforms that offer remote consultations, pain tracking, and medication reminders are enhancing patient engagement and improving treatment adherence. Forecasts indicate that digital health tools will continue to gain popularity in the analgesics market, offering patients convenient ways to manage their pain. For manufacturers, this creates opportunities to integrate digital solutions with their analgesic products, expanding the market reach and improving patient outcomes. Digital health tools can also help healthcare providers monitor patients remotely, leading to more timely interventions and optimized pain management strategies.
  • Demand for Natural and Alternative Pain Relief Options: With increasing awareness of the side effects associated with traditional analgesics, there is a rising demand for natural and alternative pain relief options. Patients are seeking more holistic approaches to pain management, including herbal remedies, acupuncture, and other non-pharmaceutical treatments. The analgesics market is evolving to include natural pain relief options, such as CBD products and plant-based therapies, which are gaining popularity due to their perceived safety and efficacy. Market forecasts suggest that the demand for natural alternatives will continue to grow as more patients seek effective, non-invasive pain management solutions. This presents an opportunity for pharmaceutical companies to diversify their product offerings, creating a niche market for natural pain relief products while meeting consumer preferences.

Market Report Scope

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Analgesics Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Analgesics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


RD Image
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
REGIONAL FRAMEWORK
World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Analgesics Market?

The Analgesics Market is estimated to witness a CAGR of 6.4% from 2025 to 2031.

What are the driving factors impacting the Analgesics Market?

The major factors driving the Analgesics Market are Increasing Prevalence of Chronic Pain Conditions, Rising Awareness of Pain Management Treatments, and Advancements in Pain Management Medications.

What are the future trends of the Analgesics Market?

Future trends in the Analgesics Market are Shift Toward Non-Opioid Pain Management, Rise in Personalized Pain Management Solutions, and Expansion of Over-the-Counter (OTC) Pain Relief Products.

Which are the leading players in the Analgesics Market?

Some of the players operating in the market are Bayer AG, Novartis AG, GlaxoSmithKline PLC, Pfizer Inc., Johnson & Johnson Services, Inc., Reckitt Benckiser (RB), Endo Pharmaceuticals, Sanofi, Eli Lilly and Company, Teva Pharmaceuticals.

What are the deliverable formats of the Analgesics Market report?

The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.

What are the options available for the customization of this report?

Some customization options available based on the request are an additional 3–5 company profiles and a country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Analgesics Market - By Product Type
1.3.2 Analgesics Market - By Route of Administration
1.3.3 Analgesics Market - By Pain Type
1.3.4 Analgesics Market - By Distribution Channel
1.3.5 Analgesics Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANALGESICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANALGESICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. ANALGESICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANALGESICS - GLOBAL MARKET OVERVIEW
6.2. ANALGESICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. ANALGESICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. NON-OPIOIDS
7.3.1. Overview
7.3.2. Non-opioids Market Forecast and Analysis
7.4. OPIOIDS
7.4.1. Overview
7.4.2. Opioids Market Forecast and Analysis

8. ANALGESICS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INTRAVENOUS
8.4.1. Overview
8.4.2. Intravenous Market Forecast and Analysis
8.5. RECTAL
8.5.1. Overview
8.5.2. Rectal Market Forecast and Analysis
8.6. TRANSDERMAL
8.6.1. Overview
8.6.2. Transdermal Market Forecast and Analysis
8.7. TOPICAL
8.7.1. Overview
8.7.2. Topical Market Forecast and Analysis

9. ANALGESICS MARKET - REVENUE AND FORECASTS TO 2028 - PAIN TYPE
9.1. OVERVIEW
9.2. PAIN TYPE MARKET FORECASTS AND ANALYSIS
9.3. SURGICAL PAIN
9.3.1. Overview
9.3.2. Surgical Pain Market Forecast and Analysis
9.4. CANCER PAIN
9.4.1. Overview
9.4.2. Cancer Pain Market Forecast and Analysis
9.5. NEUROPATHIC PAIN
9.5.1. Overview
9.5.2. Neuropathic Pain Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis

10. ANALGESICS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. DRUG STORE
10.5.1. Overview
10.5.2. Drug Store Market Forecast and Analysis
10.6. OTHERS
10.6.1. Overview
10.6.2. Others Market Forecast and Analysis

11. ANALGESICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Analgesics Market Overview
11.1.2 North America Analgesics Market Forecasts and Analysis
11.1.3 North America Analgesics Market Forecasts and Analysis - By Product Type
11.1.4 North America Analgesics Market Forecasts and Analysis - By Route of Administration
11.1.5 North America Analgesics Market Forecasts and Analysis - By Pain Type
11.1.6 North America Analgesics Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Analgesics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Analgesics Market
11.1.7.1.1 United States Analgesics Market by Product Type
11.1.7.1.2 United States Analgesics Market by Route of Administration
11.1.7.1.3 United States Analgesics Market by Pain Type
11.1.7.1.4 United States Analgesics Market by Distribution Channel
11.1.7.2 Canada Analgesics Market
11.1.7.2.1 Canada Analgesics Market by Product Type
11.1.7.2.2 Canada Analgesics Market by Route of Administration
11.1.7.2.3 Canada Analgesics Market by Pain Type
11.1.7.2.4 Canada Analgesics Market by Distribution Channel
11.1.7.3 Mexico Analgesics Market
11.1.7.3.1 Mexico Analgesics Market by Product Type
11.1.7.3.2 Mexico Analgesics Market by Route of Administration
11.1.7.3.3 Mexico Analgesics Market by Pain Type
11.1.7.3.4 Mexico Analgesics Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Analgesics Market Overview
11.2.2 Europe Analgesics Market Forecasts and Analysis
11.2.3 Europe Analgesics Market Forecasts and Analysis - By Product Type
11.2.4 Europe Analgesics Market Forecasts and Analysis - By Route of Administration
11.2.5 Europe Analgesics Market Forecasts and Analysis - By Pain Type
11.2.6 Europe Analgesics Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Analgesics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Analgesics Market
11.2.7.1.1 Germany Analgesics Market by Product Type
11.2.7.1.2 Germany Analgesics Market by Route of Administration
11.2.7.1.3 Germany Analgesics Market by Pain Type
11.2.7.1.4 Germany Analgesics Market by Distribution Channel
11.2.7.2 France Analgesics Market
11.2.7.2.1 France Analgesics Market by Product Type
11.2.7.2.2 France Analgesics Market by Route of Administration
11.2.7.2.3 France Analgesics Market by Pain Type
11.2.7.2.4 France Analgesics Market by Distribution Channel
11.2.7.3 Italy Analgesics Market
11.2.7.3.1 Italy Analgesics Market by Product Type
11.2.7.3.2 Italy Analgesics Market by Route of Administration
11.2.7.3.3 Italy Analgesics Market by Pain Type
11.2.7.3.4 Italy Analgesics Market by Distribution Channel
11.2.7.4 Spain Analgesics Market
11.2.7.4.1 Spain Analgesics Market by Product Type
11.2.7.4.2 Spain Analgesics Market by Route of Administration
11.2.7.4.3 Spain Analgesics Market by Pain Type
11.2.7.4.4 Spain Analgesics Market by Distribution Channel
11.2.7.5 United Kingdom Analgesics Market
11.2.7.5.1 United Kingdom Analgesics Market by Product Type
11.2.7.5.2 United Kingdom Analgesics Market by Route of Administration
11.2.7.5.3 United Kingdom Analgesics Market by Pain Type
11.2.7.5.4 United Kingdom Analgesics Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Analgesics Market Overview
11.3.2 Asia-Pacific Analgesics Market Forecasts and Analysis
11.3.3 Asia-Pacific Analgesics Market Forecasts and Analysis - By Product Type
11.3.4 Asia-Pacific Analgesics Market Forecasts and Analysis - By Route of Administration
11.3.5 Asia-Pacific Analgesics Market Forecasts and Analysis - By Pain Type
11.3.6 Asia-Pacific Analgesics Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Analgesics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Analgesics Market
11.3.7.1.1 Australia Analgesics Market by Product Type
11.3.7.1.2 Australia Analgesics Market by Route of Administration
11.3.7.1.3 Australia Analgesics Market by Pain Type
11.3.7.1.4 Australia Analgesics Market by Distribution Channel
11.3.7.2 China Analgesics Market
11.3.7.2.1 China Analgesics Market by Product Type
11.3.7.2.2 China Analgesics Market by Route of Administration
11.3.7.2.3 China Analgesics Market by Pain Type
11.3.7.2.4 China Analgesics Market by Distribution Channel
11.3.7.3 India Analgesics Market
11.3.7.3.1 India Analgesics Market by Product Type
11.3.7.3.2 India Analgesics Market by Route of Administration
11.3.7.3.3 India Analgesics Market by Pain Type
11.3.7.3.4 India Analgesics Market by Distribution Channel
11.3.7.4 Japan Analgesics Market
11.3.7.4.1 Japan Analgesics Market by Product Type
11.3.7.4.2 Japan Analgesics Market by Route of Administration
11.3.7.4.3 Japan Analgesics Market by Pain Type
11.3.7.4.4 Japan Analgesics Market by Distribution Channel
11.3.7.5 South Korea Analgesics Market
11.3.7.5.1 South Korea Analgesics Market by Product Type
11.3.7.5.2 South Korea Analgesics Market by Route of Administration
11.3.7.5.3 South Korea Analgesics Market by Pain Type
11.3.7.5.4 South Korea Analgesics Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Analgesics Market Overview
11.4.2 Middle East and Africa Analgesics Market Forecasts and Analysis
11.4.3 Middle East and Africa Analgesics Market Forecasts and Analysis - By Product Type
11.4.4 Middle East and Africa Analgesics Market Forecasts and Analysis - By Route of Administration
11.4.5 Middle East and Africa Analgesics Market Forecasts and Analysis - By Pain Type
11.4.6 Middle East and Africa Analgesics Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Analgesics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Analgesics Market
11.4.7.1.1 South Africa Analgesics Market by Product Type
11.4.7.1.2 South Africa Analgesics Market by Route of Administration
11.4.7.1.3 South Africa Analgesics Market by Pain Type
11.4.7.1.4 South Africa Analgesics Market by Distribution Channel
11.4.7.2 Saudi Arabia Analgesics Market
11.4.7.2.1 Saudi Arabia Analgesics Market by Product Type
11.4.7.2.2 Saudi Arabia Analgesics Market by Route of Administration
11.4.7.2.3 Saudi Arabia Analgesics Market by Pain Type
11.4.7.2.4 Saudi Arabia Analgesics Market by Distribution Channel
11.4.7.3 U.A.E Analgesics Market
11.4.7.3.1 U.A.E Analgesics Market by Product Type
11.4.7.3.2 U.A.E Analgesics Market by Route of Administration
11.4.7.3.3 U.A.E Analgesics Market by Pain Type
11.4.7.3.4 U.A.E Analgesics Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Analgesics Market Overview
11.5.2 South and Central America Analgesics Market Forecasts and Analysis
11.5.3 South and Central America Analgesics Market Forecasts and Analysis - By Product Type
11.5.4 South and Central America Analgesics Market Forecasts and Analysis - By Route of Administration
11.5.5 South and Central America Analgesics Market Forecasts and Analysis - By Pain Type
11.5.6 South and Central America Analgesics Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America Analgesics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Analgesics Market
11.5.7.1.1 Brazil Analgesics Market by Product Type
11.5.7.1.2 Brazil Analgesics Market by Route of Administration
11.5.7.1.3 Brazil Analgesics Market by Pain Type
11.5.7.1.4 Brazil Analgesics Market by Distribution Channel
11.5.7.2 Argentina Analgesics Market
11.5.7.2.1 Argentina Analgesics Market by Product Type
11.5.7.2.2 Argentina Analgesics Market by Route of Administration
11.5.7.2.3 Argentina Analgesics Market by Pain Type
11.5.7.2.4 Argentina Analgesics Market by Distribution Channel

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. ANALGESICS MARKET, KEY COMPANY PROFILES
13.1. BAYER AG
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. NOVARTIS AG
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. GLAXOSMITHKLINE PLC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. PFIZER INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. JOHNSON & JOHNSON SERVICES, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. RECKITT BENCKISER (RB)
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ENDO PHARMACEUTICALS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SANOFI
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ELI LILLY AND COMPANY
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TEVA PHARMACEUTICALS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Bayer AG
2. Novartis AG
3. GlaxoSmithKline PLC
4. Pfizer Inc.
5. Johnson & Johnson Services, Inc.
6. Reckitt Benckiser (RB)
7. Endo Pharmaceuticals
8. Sanofi
9. Eli Lilly and Company
10. Teva Pharmaceuticals

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..